Found: 20
Select item for more details and to access through your institution.
A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 6, p. 542, doi. 10.3390/jpm11060542
- By:
- Publication type:
- Article
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets.
- Published in:
- EMBO Molecular Medicine, 2024, v. 16, n. 8, p. 1791, doi. 10.1038/s44321-024-00098-y
- By:
- Publication type:
- Article
Systemic CD4 immunity: A powerful clinical biomarker for PD‐L1/PD‐1 immunotherapy.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 9, p. 1, doi. 10.15252/emmm.202012706
- By:
- Publication type:
- Article
Functional systemic CD4 immunity is required for clinical responses to PD‐L1/PD‐1 blockade therapy.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 7, p. N.PAG, doi. 10.15252/emmm.201910293
- By:
- Publication type:
- Article
Understanding LAG-3 Signaling.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 10, p. 5282, doi. 10.3390/ijms22105282
- By:
- Publication type:
- Article
Hyperprogressive Disease: Main Features and Key Controversies.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 7, p. 3736, doi. 10.3390/ijms22073736
- By:
- Publication type:
- Article
PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 16, p. 5918, doi. 10.3390/ijms21165918
- By:
- Publication type:
- Article
Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 7, p. 2411, doi. 10.3390/ijms21072411
- By:
- Publication type:
- Article
PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 7, p. 1631, doi. 10.3390/ijms20071631
- By:
- Publication type:
- Article
The intracellular signalosome of PD-L1 in cancer cells.
- Published in:
- Signal Transduction & Targeted Therapy, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41392-018-0022-9
- By:
- Publication type:
- Article
TNF-α-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.811867
- By:
- Publication type:
- Article
Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives.
- Published in:
- Archivum Immunologiae & Therapiae Experimentalis, 2018, v. 66, n. 2, p. 113, doi. 10.1007/s00005-017-0492-4
- By:
- Publication type:
- Article
Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer.
- Published in:
- EMBO Reports, 2023, v. 24, n. 8, p. 1, doi. 10.15252/embr.202255884
- By:
- Publication type:
- Article
Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?
- Published in:
- Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00441
- By:
- Publication type:
- Article
Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3846, doi. 10.3390/cancers14163846
- By:
- Publication type:
- Article
Profound Reprogramming towards Stemness in Pancreatic Cancer Cells as Adaptation to AKT Inhibition.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2181, doi. 10.3390/cancers12082181
- By:
- Publication type:
- Article
Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 344, doi. 10.3390/cancers12020344
- By:
- Publication type:
- Article
Systemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy Efficacy.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.586907
- By:
- Publication type:
- Article
The multi-specific V<sub>H</sub>-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Establishment and Characterization of a Stable Producer Cell Line Generation Platform for the Manufacturing of Clinical-Grade Lentiviral Vectors.
- Published in:
- Biomedicines, 2024, v. 12, n. 10, p. 2265, doi. 10.3390/biomedicines12102265
- By:
- Publication type:
- Article